News

An Abbreviated New Drug Application (ANDA) is the U.S. Food and Drug Administration (FDA) pathway, under section 505(j) of the...

Abstract Apixaban (APX) is a poorly water-insoluble anticoagulant drug. To enhance the solubility and dissolution profile, the APX inclusion complex...

Understanding and Reducing the Water Footprint of Pharmaceutical Lactose: The Lactalis Ingredients Pharma Approach We organized an exclusive Q&A session...

Abstract Background: Existing therapies for xerostomia are primarily symptomatic, providing temporary mucosal hydration without addressing underlying pathological changes in the...

Multiparticulate systems are increasingly changing the way pharmaceutical companies approach early drug product development. While conventional monolithic dosage forms such...

Abstract A comprehensive understanding of drugs and excipients is crucial for developing a stable pharmaceutical formulation. Pre-formulation studies include the...

Abstract Chewable tablets are a specialized oral solid dosage form designed to be chewed in the mouth prior to swallowing,...

Abstract The In-situ polymeric formulation is a drug delivery system that forms a gel upon water absorption at the site of administration....

MEGGLE introduced an interactive, science-based tool designed to help you assess nitrosamine formation risk and optimize acceptable nitrite limits in...

Abstract Objective: This study aimed to develop an oral celastrol-loaded self-microemulsifying drug delivery system (Cel-SMEDDS) to enhance the therapeutic efficacy...